There are 10 resources available
Welcome and introductions
Presenter: Marlies Wakkee
Session: Sanofi and Regeneron - Current and future roles of immunotherapy in the treatment of advanced BCC and CSCC
Resources:
Webcast
Immune modulation and tumor microenvironment
Presenter: Egle Ramelyte
Session: Sanofi and Regeneron - Current and future roles of immunotherapy in the treatment of advanced BCC and CSCC
Resources:
Webcast
Advanced BCC and CSCC clinical case presentations
Presenter: Rick Waalboer-Spuij
Session: Sanofi and Regeneron - Current and future roles of immunotherapy in the treatment of advanced BCC and CSCC
Resources:
Webcast
Shaping the future of immunotherapy in advanced BCC and CSCC
Presenter: Marlies Wakkee
Session: Sanofi and Regeneron - Current and future roles of immunotherapy in the treatment of advanced BCC and CSCC
Resources:
Webcast
Interactive panel discussion
Presenter: Marlies Wakkee
Session: Sanofi and Regeneron - Current and future roles of immunotherapy in the treatment of advanced BCC and CSCC
Resources:
Webcast
Introduction
Presenter: Solange Peters
Session: Sanofi - Utilizing immunohistochemistry testing, biomarkers, and targeted therapeutics to optimize outcomes in patients with NSCLC
Resources:
Webcast
Identification of NSCLC biomarkers and associated serum and immunohistochemistry testing
Presenter: Hossein Borghaei
Session: Sanofi - Utilizing immunohistochemistry testing, biomarkers, and targeted therapeutics to optimize outcomes in patients with NSCLC
Resources:
Webcast
Clinical trial review for biomarker-driven targeted therapeutics
Presenter: Natasha Leighl
Session: Sanofi - Utilizing immunohistochemistry testing, biomarkers, and targeted therapeutics to optimize outcomes in patients with NSCLC
Resources:
Webcast
The role of CEACAM5: Targeted therapeutics to improve outcomes in patients with CEA-positive NSCLC
Presenter: David Planchard
Session: Sanofi - Utilizing immunohistochemistry testing, biomarkers, and targeted therapeutics to optimize outcomes in patients with NSCLC
Resources:
Webcast
Conclusions
Presenter: Solange Peters
Session: Sanofi - Utilizing immunohistochemistry testing, biomarkers, and targeted therapeutics to optimize outcomes in patients with NSCLC
Resources:
Webcast